Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value

$0.82−0.06 (-6.69%)

Close on Nov 13, 2026Market cap $36.32MP/E –Yield –

Elutia ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Elutia's ebitda for the twelve months ending Sep 30, 2026 was -$24.46M. For fiscal 2025 it was -$24.13M. The highest annual figure on record is -$4.55M in fiscal 2019.

Annual ebitda

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$24.13M	–
FY2024	Dec 31, 2024	-$27.26M	–
FY2023	Dec 31, 2023	-$26.78M	–
FY2022	Dec 31, 2022	-$31.46M	–
FY2021	Dec 31, 2021	-$19.30M	–
FY2020	Dec 31, 2020	-$9.74M	–
FY2019	Dec 31, 2019	-$4.55M	–

Quarterly ebitda

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$6.49M	–
Q2 FY2026	Jun 30, 2026	-$7.61M	–
Q1 FY2026	Mar 31, 2026	-$6.02M	–
Q4 FY2025	Dec 31, 2025	-$4.34M	–
Q3 FY2025	Sep 30, 2025	-$5.14M	–
Q2 FY2025	Jun 30, 2025	-$7.47M	–
Q1 FY2025	Mar 31, 2025	-$5.91M	–
Q4 FY2024	Dec 31, 2024	-$6.60M	–
Q3 FY2024	Sep 30, 2024	-$8.31M	–
Q2 FY2024	Jun 30, 2024	-$7.65M	–
Q1 FY2024	Mar 31, 2024	-$7.62M	–
Q4 FY2023	Dec 31, 2023	-$7.61M	–
Q3 FY2023	Sep 30, 2023	-$6.42M	–
Q2 FY2023	Jun 30, 2023	-$5.36M	–
Q1 FY2023	Mar 31, 2023	-$7.39M	–
Q2 FY2022	Jun 30, 2022	-$7.25M	–
Q1 FY2022	Mar 31, 2022	-$5.99M	–
Q4 FY2021	Dec 31, 2021	-$6.83M	–
Q3 FY2021	Sep 30, 2021	-$6.04M	–
Q2 FY2021	Jun 30, 2021	-$3.66M	–
Q1 FY2021	Mar 31, 2021	-$2.77M	–
Q4 FY2020	Dec 31, 2020	-$3.02M	–
Q3 FY2020	Sep 30, 2020	-$1.72M	–
Q2 FY2020	Jun 30, 2020	-$2.79M	–
Q1 FY2020	Mar 31, 2020	-$2.21M	–
Q4 FY2019	Dec 31, 2019	-$2.24M	–